Home Australian Developments With Regard To Regulation of Embryonic Stem Cell Research and Therapeutic Human Cloning
Article
Licensed
Unlicensed Requires Authentication

Australian Developments With Regard To Regulation of Embryonic Stem Cell Research and Therapeutic Human Cloning

  • Margaret Otlowski

    Professor of Law, Deputy Director, Centre for Law and Genetics, University of Tasmania

Published/Copyright: March 11, 2008
Become an author with De Gruyter Brill
Journal of international biotechnology law
From the journal Volume 5 Issue 1

Abstract

Introduction

Stem cell research involving the use of embryos has been controversial in Australia and internationally, and at times has triggered emotive debates. This is because isolation of embryonic stem cells inevitably entails destruction of the embryo. Controversy is also fuelled by the interconnection between this debate and the debate about human cloning. Although there is by no means a consensus on the approach that should be taken to the regulation of this area, there is at least wide acceptance of the significant potential of stem cell research and the need to ensure that scientific progress in this field is not stymied by overly restrictive laws. The aim of this paper is to sketch the background to the regulation in Australia of stem cell research and human cloning, and to outline the current regulatory model as modified by amending legislation in 2006 to permit so called ‘therapeutic cloning’.

About the author

Margaret Otlowski

Professor of Law, Deputy Director, Centre for Law and Genetics, University of Tasmania

Published Online: 2008-03-11
Published in Print: 2008-01-01

© Walter de Gruyter

Downloaded on 31.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/JIBL.2008.08/html
Scroll to top button